Most Popular
Alnylam Pharmaceuticals: Preliminary Full-Year ’23 Revenues Boast 39% Growth
Alnylam Pharmaceuticals ALNY reported a noteworthy 39% growth in full-year 2023 net product revenues, amounting to $1.24 billion. This surpassed Zacks Consensus Estimate’s projection ...
American Public Education – Meteoric Rise on Enrollment Surge
American Public (APEI) Up 117% in 3 Months on Solid Enrollment
American Public Education, Inc. (APEI) has risen an astonishing 117.4% in the past three months, benefiting significantly from strong performances by the American Public ...
Nvidia’s True Value Unveiled
Nvidia’s True Value Unveiled
The Nvidia Investment Opportunity Data by YCharts Nvidia Corporation’s (NASDAQ:NVDA) meteoric rise in 2023 has fueled misconceptions about its valuation. Contrary to popular belief, ...
Assessing Dave & Buster’s (PLAY) Investment — Wall Street’s Encouraging Stance
Assessing Dave & Buster’s (PLAY) Investment — Wall Street’s Encouraging Stance
Brokers are a stock investor’s North Star. But, can the views of these Wall Street pros actually guide your investment moves? Before we delve ...
Why Kirby Corporation (KEX) Is a Compelling Investment Option
Why Kirby Corporation (KEX) Is a Compelling Investment Option
Investors, listen up. Outstanding Performance and Future Potential Kirby Corporation (KEX) has been on a winning streak, and there’s every indication that this is just ...
Wall Street Analysts’ Perspective on Super Micro’s Future Stock Performance
Wall Street Analysts’ Perspective on Super Micro’s Future Stock Performance
Before diving into the reliability of brokerage recommendations, let’s take a look at what Wall Street analysts have to say about Super Micro Computer ...
UMH Properties Sees Escalating Occupancy and Rental Revenue Amidst Robust Demand
UMH Properties: A Recap of 2023 UMH Properties recently revealed its operational results for the year concluded in 2023, highlighting an upsurge in the ...
2024 Preview: Latin America VC Industry
This article is part of the LatAm Tech Weekly Series, written by Julia De Luca and powered by Nasdaq. Through Nasdaq’s global network, we partner with Latin ...
Acadia Healthcare: A Prescription for Portfolio Success
Why Acadia Healthcare is a Prescription for Portfolio Success
Acadia Healthcare Company, Inc. ACHC is strategically poised for growth, driven by increasing admissions and expansion in Medicare, Medicaid, and commercial businesses. The growing ...
Investors Eye AKYA, DRTS, and TRUP as Top Momentum Stocks
A trio of stocks is turning heads today with their impressive buy rank and robust momentum. The allure of starting off 2024 with these ...
